Treatment of systemic mast cell disorders

Hematology/Oncology Clinics of North America

Volumn 14, Issue 3, 2000, Pages 659-687

  Worobec, Alexandra S ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA2B INTERFERON; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CETIRIZINE; CHLORPHENIRAMINE; CIMETIDINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYPROHEPTADINE; CYTARABINE; DIPHENHYDRAMINE; DOXEPIN; FAMOTIDINE; FEXOFENADINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYZINE; KETOTIFEN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; MITHRAMYCIN; MONTELUKAST; OPIATE; PAMIDRONIC ACID; PROCARBAZINE; RANITIDINE; UNINDEXED DRUG; ZAFIRLUKAST;

CLINICAL FEATURE; CLINICAL TRIAL; DISEASE CLASSIFICATION; DRUG ABSORPTION; DRUG CONTRAINDICATION; HEMATOLOGIC DISEASE; HUMAN; MALABSORPTION; MAST CELL; MAST CELL LEUKEMIA; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; PUVA; REVIEW; STOMACH ACID SECRETION; SYSTEMIC MASTOCYTOSIS; TREATMENT OUTCOME; URTICARIA PIGMENTOSA;

EID: 0033945410     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70301-4     Document Type: Article

References (174)

1. Abdullah AN, Keczkes K: Cutaneous and ocular side-effects of PUVA photochemo-therapy - A 10-year follow-up study. Clin Exp Dermatol 14:421, 1989
2. Achord JL, Langford H: The effect of Cimetidine and propantheline on the symptoms of a patient with systemic mastocytosis. Am J Med 69:610, 1980
3. Akin C, Metcalfe DD: Mastocytosis. In Leung D, Greaves M (eds): Allergic Skin Diseases. New York, Marcel Dekker, 2000, pp 237-352
4. Alexander RR: Disodium cromoglycate in the treatment of systemic mastocytosis involving only bone. Acta Haematol 74:108, 1985
5. Allison MA, Schmidt CP: Urticaria pigmentosa. Int J Dermatol 36:321, 1997
6. Alto WA, Clarcq L: Cutaneous and systemic manifestations of mastocytosis. Am Fam Physician 59:3059, 1999
7. Apter AJ, Rothe MJ: Referred for management of mastocytosis. Ann Allergy Asthma Immunol 79:21, 1997
8. Balato N, Bordone F, Patruno C, et al: Bullous mastocytosis. Two clinical cases. Minerva Pediatr 44:555, 1992
9. Barton J, Lakver RM, Schechter NE, et al: Treatment of urticaria pigmentosa with corticosteroids. Arch Dermatol 121:1516, 1985
10. Berg MJ, Bernhard H, Schentag JJ: Cimetidine in systemic mastocytosis. Drug Intelligence and Clinical Pharmacy 15:180, 1981
11. Bianchine PJ, Metcalfe DD: Systemic mastocytosis. In Kaplan AP (ed): Allergy. Philadelphia, WB Saunders, 1997, pp 854-860
12. Bletry O, Papo T: Interferons alpha and gamma: Indications in systemic diseases. Ann Med Interne (Paris) 144:557, 1993
13. Bonnet P, Smadja C, Szekely A-M: Intractable ascites in systemic mastocytosis treated by portal diversion. Dig Dis Sci 32:209, 1987
14. Borgeat A, Ruetsch YA: Anesthesia in a patient with malignant systemic mastocytosis using a total intravenous anesthetic technique. Anesth Analg 86:442, 1998
15. Bredfeldt JE, O'Laughlin JC, Durham JB, et al: Malabsorption and gastric hyperacidity in systemic mastocytosis. Results of Cimetidine therapy. Am J Gastroenterol 74:133, 1980
16. Brunei V, Tadrist Z, Cailleres S, et al: Interferon alpha and Pamidronate: A useful combination in the treatment of osteoporosis and systemic mastocytosis [letter]. Presse Med 17:64, 1998
17. Buhl K, Clearfield HR: Omeprazole: A new approach to gastric acid suppression. Am Fam Physician 41:1225, 1990
18. Businco L, Cantani A, Businco E, et al: Systemic mastocytosis in a 5-year-old child: Successful treatment with disodium cromoglycate. Clin Allergy 14:147, 1984
19. Butterfield JH: Response of severe systemic mastocytosis to interferon alpha. Br J Dermatol 138:489, 1998
20. Butterfield JH, Kao PC, Klee GC, et al: Aspirin idiosyncrasy in systemic mast cell disease: A new look at mediator release during aspirin desensitization. Mayo Clin Prod 70:481, 1995
21. Castellano GP, Barcia-Erce JN, Alegret AR, et al: Interferon alfa and systemic mastocytosis. Analysis of therapeutic efficacy in 6 cases. Rev Clin Esp 198:345, 1998
22. Cervero C, Escribano L, San Miguel JF, et al: Expression of Bcl-2 by human bone marrow mast cells and its overexpression in mast cell leukemia. Am J Hematol 60:191, 1999
23. Chosidow O, Becherel PA, Piette JC, et al: Tripe palms associated with systemic mastocytosis: The role of transforming growth factor-alpha and efficacy of interferon-alfa. Br J Dermatol 138:698, 1998
24. Christophers E, Honigsmann H, Wolff K, et al: PUVA-treatment of urticaria pigmentosa. Br J Dermatol 98:701, 1978
25. Clancy RL, Gaulde J, Vallieres M, et al: An approach to immunotherapy: Antibody to IgE in mast cell leukemia. Cancer 37:693, 1976
26. Cohn MS, Mahon MJ: Telangiecstasia macularis eruptiva perstans. J Am Osteopath Assoc 94:246, 1994
27. Conrad ME, Carpenter JJ Jr, Todd JN III, et al: Mithramycin in the treatment of systemic mastocytosis. Ann Intern Med 83:659, 1975
28. Cooper AJ, Winkelmann RK, Wiltsie JC: Hematologic malignancies occurring in patients with urticaria pigmentosa. Am Acad Dermatol 7:215, 1982
29. Cox JV, Balaban EP, Demian SE, et al: An eosinophilic fibrohistiocytic lesion of bone marrow in a patient with Hodgkin's disease. Cancer 68:1824, 1991
30. 2) antagonists and cyclooxygenase inhibition. Clin Invest Med 10:1, 1987
31. Cundy T, Beneton MNC, Darbyt JA, et al: Osteopenia in systemic mastocytosis: Natural history and responses to treatment with inhibitors of bone resorption. Bone 8:149, 1987
32. Czarnetzki MB, Behrendt H: Urticaria pigmentosa: Clinical picture and response to oral disodium cromoglycate. Br J Dermatol 105:563, 1981
33. Czarnetzki BM: A double-blind cross-over study of the effect of ketotifen in urticaria pigmentosa. Dermatologia 166:44, 1983
34. Czarnetzki BM, Rosenbach T, Kolde G, et al: Phototherapy of urticaria pigmentosa: Clinical response and changes of cutaneous reactivity, histamine, and chemotactic leukotrienes. Arch Dermatol Res 277:105, 1985
35. Czarnetzki BM, Algermissen B, Jeep S, et al: Interferon treatment of patients with chronic urticaria and mastocytosis. J Am Acad Dermatol 30:500, 1994
36. Dalton R, Chan L, Batten E, et al: Mast cell leukemia: Evidence for bone marrow origin of the pathological clone. Br J Haematol 64:397, 1986
37. De las Nieves M, Poveda F, Queipo de Llano MP, et al: Systemic mastocytosis: Presentation of a case evolving into myelofibrosis and no response to interferon alfa 2b [letter]. Sangre (Barc) 42:430, 1997
38. Debeuckeaere S, Schoors DF, Devis G: Systemic mast cell disease: A review of the literature with special focus on the gastrointestinal manifestations. Acta Clin Belg 46:226, 1991
39. Delaporte E, Pierard E, Wolthers BG, et al: Correspondence: Interferon-α in combination with corticosteroids improves systemic mast cell disease. Br J Dermatol 132:479, 1995
40. D'Inca M, Ghirarduzzi A, Albertini G, et al: Systemic mastocytosis: A review of the literature and of the cases in Reggio Emilia from 1986 to 1994. Ann Ital Med Int 11:52, 1996
41. Ebeling PR: Osteoporosis in men: New insights into aetiology, pathogenesis, prevention, and management. Drugs Aging 13:421, 1998
42. Ellis DL: Treatment of telangiectasia macularis eruptiva perstans with the 585-nm flashlamp-pumped dye laser. Dermatol Surg 22:33, 1996
43. Engler RJM, Davis WS: Rush Hymenoptera venom immunotherapy: Successful treatment in a patient with systemic mast cell disease. J Allergy Clin Immunol 94:556,1994
44. Enomoto U, Kusakabe H, Matsumura T, et al: Diffuse cutaneous mastocytosis responding to cyproheptadine. Clin Exp Dermatol 24:16, 1999
45. Escribano L, Orfao A, Vallarrubia J, et al: Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia. Cytometry 30:98, 1997
46. Essner C, Thiefin G, Diebold MD, et al: Lymphocytic ascites revealing systemic mastocytosis. Gastroenterol Clin Biol 19:948, 1995
47. Fain O, Sitbon M, Sibony M, et al: Efficacite de l'interferon alpha dans un cas de mastocytose systemique. Ann Med Interne (Paris) 146:205, 1995
48. 2-receptor antagonists. Arch Dermatol 121:115, 1985
49. Fiehn C, Prummer O, Gallati H, et al: Treatment of systemic mastocytosis with interferon-γ: Failure after appearance of anti-IFN-γ antibodies. Eur J Clin Invest 25:615, 1995
50. Fodinger M, Mannhalter C: Molecular genetics and development of mast cells: Implications for molecular medicine. Mol Med Today 3:131, 1997
51. Fodinger M, Fritsch G, Winkler K, et al: Origin of human mast cells: Development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation. Blood 84:2954, 1994
52. Fonga-Djimi HS, Gottrand F, Bonnevalle M, et al: A fatal case of portal hypertension complicating systemic mastocytosis in an adolescent. Eur J Pediatr 154:819, 1995
53. Friedman B, Darling G, Norton J, et al: Splenectomy in the management of systemic mast cell disease. Surgery 107:94, 1990
54. Friedman BS, Metcalfe DD: Effects of tixocortal pivalate on gastrointestinal disease in systemic mastocytosis: A preliminary study. Clin Exp Allergy 21:181, 1991
55. Friedman BS, Santiago ML, Berkebile C, et al: Comparison of azelastine and chlorpheniramine in the treatment of mastocytosis. J Allergy Clin Immunol 92:520, 1993
56. Frieri M, Alling DW, Metcalfe DD: Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and Cimetidine in systemic mastocytosis. Am J Med 78:9, 1985
57. Gasior-Chrzan B, Falk ES: Systemic mastocytosis treated with histamine H1 and H2 receptor antagonists. Dermatology 184:149, 1992
58. Gazca Aguilar A, Frias Castro LO, Balbuena Rosas EJ, et al: Mastocytosis in children. Report of 3 cases. Rev Alerg Mex 43:84, 1996
59. Genovese A, Spadaro G, Triggiani M, et al: Clinical advances in mastocytosis. Int J Clin Lab Res 25:178, 1995
60. Godt O, Proksch E, Streit V, et al: Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis. Dermatology 195:35, 1997
61. Goins VA: Mastocytosis. Perioperative considerations. AORN J 54:1227, 1991
62. Gonera RK, Oranje WA, Wolffenbuttel BH: Shock of unknown origin-Think of mastocytosis! Neth J Med 50:165, 1997
63. Golkar L, Bernhard JD: Mastocytosis. Lancet 349:1379, 1997
64. Granerus G, Lonnqvist B, Roupe G: Histamine metabolism in mastocytosis patients treated with interferon α-2b. Inflamm Res 45 (suppl 1):S41, 1996
65. Griesinger F, Bergmann L, Mitrou PS: Interferons in the treatment of malignant mastocytosis (MM) and CMMol. Blut 55:309, 1987
66. Gruchalla RS: Southwestern Internal Medicine Conference: Mastocytosis: Developments during the past decade. Am J Med Sci 309:328, 1995
67. Guzzo C, Lavker R, Roberts LJ III, et al: Urticaria pigmentosa: Systemic evaluation and successful treatment with topical steroids. Arch Dermatol 127:191, 1991
68. Hagen W, Schwarzmeier J, Walchshofer S, et al: A case of bone marrow mastocytosis associated with multiple myeloma. Ann Hematol 76:167, 1998
69. Harrison BD, Ashford RA, Hatton CS: Systemic mastocytosis - A case treated with interferon alpha and radiotherapy. Clin Lab Haematol 16:291, 1994
70. Haustein UF, Bedri M: Bullous mastocytosis in a child. Hautarzt 48:127, 1997
71. Higgins EM, Humphreys S, Duvivier AW: Urticaria pigmentosa-Response to topical steroids. Clin Exp Dermatol 19:438, 1994
72. Hirschowitz BI, Groarke JF: Effect of Cimetidine on gastric hypersecretion and diarrhea in systemic mastocytosis. Ann Intern Med 90:769, 1979
73. Horan RF, Sheffer AL, Austen KF: Cromolyn sodium in the management of systemic mastocytosis. J Allergy Clin Immunol 85:852, 1990
74. Horan RF, Austen KF: Systemic mastocytosis: Retrospective review of a decade's clinical experience at the Brigham and Women's Hospital. J Invest Dermatol 96:5S, 13S, 1991
75. Jackson A, Burton IE: A case of POEMS syndrome associated with essential thrombo-cythemia and dermal mastocytosis. Postgrad Med 66:761, 1990
76. Jane SM, Sutherland R, Salem HH: Malignant systemic mastocytosis. Aust N Z Med 18:610, 1988
77. Janjan NA, Conway P, Lundberg J, et al: Radiation therapy in a case of systemic mastocytosis: Evaluation of histamine levels and mucosal effects. Am J Clin Oncol 15:337, 1992
78. Jensen RT, Collen MJ, McArther KE, et al: Comparison of the effectiveness of ranitidine and Cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states. Am J Med 77:90, 1984
79. Johansson C, Roupe G, Lindstedt G, et al: Bone density, bone markers and bone radiological features in mastocytosis. Age Ageing 25:1, 1996
80. Johnson KB (ed): The Harriet Lane Handbook. St. Louis, Mosby Year-Book, 1993
81. Johnson GJ, Silvis SE, Roitman B, et al: Long-term treatment of systemic mastocytosis with histamine H2 receptor antagonists. Am J Gastroenterol 74:485, 1980
82. Johnstone PAS, Mican JM, Metcalfe DD, et al: Radiotherapy of refractory bone pain due to systemic mast cell disease. Am J Clin Oncol 17:328, 1994
83. Kasimov N: A telangiectatic clinical variant of mastocytosis. Vestnik Dermatologii i Venerologii 11:52, 1990
84. Katoh N, Hirano S, Yasuno H: Solitary mastocytoma treated with tranilast. J Dermatol 23:335, 1996
85. Kemink SA, Smals AG, Kloppenborg PW: Systemic mastocytosis as a cause of osteoporosis. Ned Tijdschr Geneedskd 140:1277, 1996
86. Kettelhut BV, Metcalfe DD: Pediatric mastocytosis. Annals of Allergy 73:197, 1994
87. Kettelhut BV, Metcalfe DD: Pediatric mastocytosis. J Invest Dermatol 96:15S, 1991
88. Kettelhut BV, Berkebile C, Bradley D, et al: A double-blind, placebo-controlled, crossover trial of ketotifen versus hydroxyzine in the treatment of pediatric mastocytosis. J Allergy Clin Immunol 83:866, 1989
89. Kluin-Nelemans HC, Jansen JH, Breukelman H, et al: Successful treatment of systemic mastocytosis with interferon-alpha 2b. Blood 78:120, 1991
90. Kluin-Nelemans HC, Jansen JH, Breukelman H, et al: Response to interferon alfa-2b in a patient with systemic mastocytosis. N Engl J Med 326:619, 1992
91. Kolde G, Frosch PJ, Czarnetzki BM, et al: Response of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: Histomorphometric, ultrastructural, and biochemical investigations. J Invest Dermatol 83:175, 1984
92. Kolde G, Sunderkotter C, Luger TA: Treatment of urticaria pigmentosa using interferon alpha. Br J Dermatol 133:91, 1995
93. Krause LB, Shuster S: Minimal effect of complete H1 receptor blockade on urticaria pigmentosa. Acta Derm Venereol 65:338, 1985
94. Krutmann J: High-dose ultraviolet A1 (UVA1) phototherapy: Does it work? Photodermatol Photoimmunol Photomed 13:78, 1997
95. Kurosawa M, Amano H, Kanbe N, et al: Response to cyclosporin and low-dose methylprednisolone in aggressive systemic mastocytosis. J Allergy Clin Immunol 103(5 Pt 2):S412, 1999
96. Kyriakou D, Kouroumalis E, Konsolas J, et al: Systemic mastocytosis: A rare case of noncirrhotic portal hypertension simulating autoimmune cholangitis-Report of four cases. Am J Gastroenterol 93:106, 1998
97. Lavker RM, Schechter NM: Cutaneous mast cell depletion results from topical corticosteroids usage. J Immunol 135:2368, 1985
98. Lawrence JB, Friedman BS, Travis WD, et al: Hematologic manifestations of systemic mast cell disease: A prospective study of laboratory and morphologic features and their relation to prognosis. Am J Med 91:612, 1991
99. Lazarus GS: Mastocytosis: New understandings in cutaneous pathophysiology. J Dermatol 23:769, 1996
100. Le Cam MT, Wolkenstein P, Cosnes A, et al: Acute mast cell leukemia disclosed by vasomotor flushing. Ann Dermatol Venereol 124:621, 1997
101. Lee HP, Yoon DH, Kim CW, et al: Solitary mastocytoma on the palm. Pediatr Dermatol 15:386, 1998
102. Lehmann T, Beyeler C, Lammie B, et al: Case report: Severe osteoporosis due to systemic mast cell disease: Successful treatment with interferon alpha-2b. Br J Rheumatol 35:898, 1996
103. Lerno G, Slaats G, Coenen E, et al: Anaesthetic management of systemic mastocytosis. Br J Anaesth 65:254, 1990
104. Lippert U, Henz BM: Long-term effect of interferon alpha treatment in mastocytosis. Br J Dermatol 134:1164, 1996
105. Longley J, Duffy TP, Kohn S: The mast cell and mast cell disease. J Am Acad Dermatol 32:545, 1995
106. Lorcerie B, Arveux I, Chauffert B, et al: Aspirin and systemic mastocytosis [letter]. Lancet 2:1155, 1989
107. Lortholary O, Casassus P, Laroche L, et al: Systemic mastocytosis and malignant mastocytosis. Presse Med 19:125, 1990
108. Luger TA: Cytokine treatment of mast-cell-mediated skin diseases. Exp Dermatol 4:277, 1995
109. Mackay S, Pride HB, Tyler WB: Diffuse cutaneous mastocytosis: Treatment with oral psoralen plus UV-A. Arch Dermatol 132:1429, 1996
110. Mallet AE, Norris P, Rendell NB, et al: The effect of disodium cromoglycate and ketotifen on the excretion of histamine and N tau-methylimidazole acetic acid in urine of patients with mastocytosis. Br J Clin Pharmacol 27:88, 1989
111. Mardones P, Moyano C, Pena K, et al: Systemic mastocytosis: Clinical case. Rev Med Chil 126:823, 1998
112. Marone G, Spadaro G, Genovese A: Biology, diagnosis, and therapy of mastocytosis. Chem Immunol 62:1, 1995
113. Marshall A, Kavanagh RT, Crisp A: The effect of Pamidronate on lumbar spine bone density and pain in osteoporosis secondary to systemic mastocytosis. Br J Rheumatol 36:393, 1997
114. Metcalfe DD: Classification and diagnosis of mastocytosis: Current status. J Invest Dermatol 96:2S, 1991
115. Metcalfe DD: The treatment of mastocytosis: An overview. J Invest Dermatol 96:55S, 1991
116. Metcalfe DD: Conclusions. Clinical advances in mastocytosis: An interdisciplinary round table discussion. J Invest Dermatol 96:64S, 1991
117. Metcalfe DD: Mastocytosis. In Bennett JC, Plum F (eds): Cecil Textbook of Medicine. Philadelphia, WB Saunders Company, 1996, pp 1435-1437
118. Metcalfe DD: Mastocytosis syndromes. In Middleton E Jr, Ellis EF, Yunginger JW, et al, (eds): Allergy: Principles and Practice, St. Louis, Mosby-Year Book, 1998, pp 1093-1103
119. Moret H, Plihal E, Saudan Y: Case report of bone mastocytosis: Total hip arthroplasty for osteoarthritis and open reduction for condylar fracture of the knee. Clin Rheumatol 13:616, 1994
120. Nabeshima M, Kumakiri M, Ohkawara A: Correspondence: Long-term effect of interferon alpha treatment in mastocytosis. Br J Dermatol 134:1164, 1996
121. Olgun N, Oren H, Oren B, et al: Diffuse cutaneous mastocytosis with bone marrow infiltration. Dermatology 197:127, 1993
122. Oude Elberink JN, de Monchy JG, Kors JW, et al: Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis. J Allergy Clin Immunol 99:153, 1997
123. Pankow W, Ehlenz K, Buhr T, et al: Osteoporotic vertebral fractures in systemic mastocytosis without skin involvement. Dtsch Med Wochenschr 117:1717, 1992
124. Pardini S, Bosincu L, Bonfigli S, et al: Anaphylactic-like syndrome in systemic mastocytosis treated with alpha-2 interferon [letter]. Acta Haematol 85:220, 1991
125. Pari F, Zamagni MD, Carnevali C, et al: Systemic mastocytosis. A review of current diagnostic and therapeutic approaches. Recenti Prog Med 90:169, 1999
126. Parker RI: Hematologic aspects of mastocytosis: II: Management of hematologic disorders in association with systemic mast cell disease. J Invest Dermatol 96:52S, 1991
127. Pauls JD, Brems J, Pockros PJ, et al: Mastocytosis: Diverse presentations and outcomes. Arch Intern Med 159:401, 1999
128. Petit A, Pulik M, Gaulier A, et al: Systemic mastocytosis associated with chronic myelomonocytic leukemia: Clinical features and response to interferon alfa therapy. J Am Acad Dermatol 32:850, 1995
129. Physicians Desk Reference. Montvale, NJ, Medical Economics Co., 1999
130. Pignon J-M, Giraudier S, Duquesnoy P, et al: A new c-kit mutation in a case of aggressive mast cell disease. Br J Haematol 96:374, 1997
131. Polderman MCA, Pavel S, Vermeer BJ, et al: Toepassingen van ultraviolet-A-1-licht binnen de fotodermatologie. Ned Tijdschr Geneeskd 143:931, 1999
132. Poterack CD, Sheth KJ, Henry DP, et al: Shock in an infant with bullous mastocytosis. Pediatr Dermatol 6:122, 1989
133. Povoa A, Ducla-Soares J, Fernandes A, et al: A case of systemic mastocytosis: Therapeutic efficacy of ketotifen. J Intern Med 229:475, 1991
134. Prummer O, Fiehn C, Gallati H: Anti-interferon-γ antibodies in a patient undergoing interferon-γ treatment for systemic mastocytosis. J Interferon Cytokine Res 16:519, 1996
135. Przepiorka D, Giralt S, Khouri I, et al: Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: Review of forty cases. Am J Hematol 57:24, 1998
136. Reinacher-Schick A, Petrasch S, Longley BJ, et al: c-kit mutation and osteoporosis-like osteopathy in a patient with systemic mast cell disease. Ann Hematol 77:131, 1998
137. Reisberg IR, Oyakawa S: Mastocytosis and malabsorption, myelofibrosis and massive ascites. Am J Gastroenterol 82:54, 1987
138. Roberts LJ II, Turk JW, Oates JA: Shock syndrome associated with mastocytosis: Pharmacologic reversal of the acute episode and therapeutic prevention of recurrent attacks. Advances in Shock Research 8:145, 1982
139. Roca Miralies M, Cambazard F, Castells Rodellas A: Bullous mastocytosis (diffuse cutaneous mastocytosis): Report of a case a review of the literature. An Esp Pediatr 39:69, 1993
140. Ronnov-Jessen D, Lovgreen Nielsen P, Horn T: Persistence of systemic mastocytosis after allogeneic bone marrow transplantation in spite of complete remission of the associated myelodysplastic syndrome. Bone Marrow Transplant 8:413, 1991
141. Safyan EL, Veerabagu MP, Swerdlow SH, et al: Intrahepatic cholestasis due to systemic mastocytosis: A case report and review of literature. Am J Gastroenterol 92:1197, 1997
142. Saletti P, Ghielmini M, Scalli G, et al: Hodgkin's and Castleman's disease in a patient with systemic mastocytosis. Ann Hematol 78:97, 1999
143. Sarkany RP, Monk BE, Handfield-Jones SE: Telangiectasia macularis eruptiva perstans: A case report and review of the literature. Clin Exp Dermatol 23:38-39, 1998
144. Sartori PCE, Taylor MH, Stevens MCG, et al: Treatment of childhood acute myeloid leukemia using the BFM-83 protocol. Med Pediatr Oncol 21:8, 1993
145. Sewell KL: Immunotherapy and other novel therapies, including biologic response modifiers, apheresis, and dietary modifications. Curr Opin Rheumatol 5:293, 1993
146. Smith ML, Orton PW, Chu H, et al: Photochemotherapy of dominant, diffuse, cutaneous mastocytosis. Pediatr Dermatol 7:251, 1990
147. Soter NA, Austen KF, Wasserman SI: Oral disodium cromoglycate in the treatment of systemic mastocytosis. N Engl J Med 301:465, 1979
148. Stege H, Schopf E, Ruzicka T, et al: High-dose UVA1 for urticaria pigmentosa. Lancet 347:64, 1996
149. Sugita K, Kaneko T, Sekine Y, et al: Mast cell leukemia evolved from RAEB-T (5q-syndrome) in a 12-year-old girl. Rinsho Ketsueki 37:430, 1996
150. Takasaki Y, Tsukasaki K, Jubashi T, et al: Systemic mastocytosis with extensive polypoid lesions in the intestines: Successful treatment with interferon-α. Intern Med 37:484, 1998
151. Tebbe B, Stavropoulos PG, Krasagakis K, et al: Cutaneous mastocytosis in adults. Evaluation of 14 patients with respect to systemic disease manifestations. Dermatology 197:101, 1998
152. Teitell M, Rowland JM: Systemic mast cell disease associated with primary ovarian mixed malignant germ cell tumor. Hum Pathol 30:1546, 1998
153. Teuber SS, Vogt PJ: An unproven technique with potentially fatal outcome: Provocation/neutralization in a patient with systemic mastocytosis. Ann Allergy Asthma Immunol 82:61, 1999
154. Tharp MD: The spectrum of mastocytosis. Am J Med Sci 289:119, 1985
155. Torrey E, Simpson K, Wilbur S, et al: Malignant mastocytosis with circulating mast cells. Am J Hematol 34:283, 1990
156. Travis WD, Li C-Y, Bergstralh EJ, et al: Systemic mast cell disease: Analysis of 58 cases and literature review. Medicine 67:345, 1988
157. Travis WD, Li C-Y, Bergstralh EJ: Solid and hematologic malignancies in 60 patients with systemic mast cell disease. Arch Pathol Lab Med 113:365, 1989
158. Travis WD, Li C-Y, Hoagland HC, et al: Mast cell leukemia: Report of a case and review of the literature. Mayo Clin Proc 61:596, 1986
159. Turk J, Oates JA, Roberts LJ II: Intervention with epinephrine in hypotension associated with mastocytosis. J Allergy Clin Immunol 71:189, 1983
160. Valent P: Biology, classification and treatment of human mastocytosis. Wien Klin Wochenschr 108:385, 1996
161. Van Furth AM, Van de Rhee JH, Van Zwieten PH, et al: Congenital bullous urticaria pigmentosa. Tijdschrift Voor Kindergeneeskunde 61:58, 1993
162. Van Hoof A, Criel A, Louwagie A, et al: Cutaneous mastocytosis after autologous bone marrow transplantation. Bone Marrow Transplant 8:151, 1991
163. Van Linthoudt D, Olah AJ, Humair L, et al: Isolated bone marrow mastocytosis: A rare cause of osteoporosis not to be missed. Schweiz Rundsch Med Prax 83:189, 1994
164. Vellabriffa D, Eady RAJ, James MP, et al: Photochemotherapy (PUVA) in the treatment of urticaria pigmentosa. Br J Dermatol 109:67, 1983
165. Velloso ED, Beitier B, Chamone DA: Benign systemic mastocytosis: Report of 2 cases. Rev Hosp Clin Fac Med Sao Paolo 46:94, 1991
166. Walton J: Mastocytosis/vasodilatory shock in a 25-year-old woman. Journal of Emergency Nursing 15:356, 1989
167. Weide R, Ehlenz K, Lorenz W, et al: Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2b. Ann Hematol 72:41, 1996
168. Welch EA, Alper JC, Bogaars H, et al: Treatment of bullous mastocytosis with diso-dium cromoglycate. J Am Acad Dermatol 9:349, 1983
169. Wimazal F, Sperr WR, Horny HP, et al: Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells. Am J Hematol 61:6, 1999
170. Wong KF, Chan JK, Chan JC, et al: Concurrent acute myeloid leukemia and systemic mastocytosis. Am J Hematol 38:243, 1991
171. Worobec AS, Kirshenbaum AS, Schwartz AB, et al: Treatment of three patients with systemic mastocytosis with interferon alpha-2b. Leuk Lymphoma 18:179, 1995
172. Worobec AS, Metcalfe DD: In Fauci AS, Lichtenstein LB (eds): Current Therapy in Allergy, Immunology, and Rheumatology. St. Louis, Mosby-Year Book, 1996, pp 170-177
173. Worobec AS, Semere T, Nagata H, et al: Clinical correlates of the presence of the Asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis. Cancer 83:2120, 1998
174. Zachariae H, Herlin T, Larsen PO: Oral disodium cromoglycate in mastocytosis. Acta Derm Venereol 61:272, 1981.